Table 4.
Olive oil (a) | C4-Dietary oil (b) | Carrot (c) | P value | |
---|---|---|---|---|
GLP-1 pt | 55.38 ± 8.04 | 57.31 ± 5.68 | 38.08 ± 11.98 | 0.27 |
GLP-1 pv | 20.77 ± 1.86 | 18.77 ± 1.59 | 13.69 ± 1.33 | 0.012a>c |
GIP pt | 62.31 ± 5.30 | 56.92 ± 7.17 | 43.85 ± 7.08 | 0.15 |
GIP pv | 68.85 ± 9.24 | 38.92 ± 7.10 | 19.54 ± 2.46 | < 0.0001a>b>c |
PYY pt | 56.92 ± 11.79 | 97.31 ± 13.05 | 40.38 ± 9.24 | 0.0061b>c |
PYY pv | 93.77 ± 10.77 | 82.92 ± 12.45 | 79.08 ± 9.72 | 0.59 |
Glucose pt | 54.23 ± 8.49 | 63.08 ± 10.93 | 49.62 ± 6.06 | 0.61 |
Glucose pv | 9.89 ± 1.05 | 10.28 ± 1.13 | 10.84 ± 1.22 | 0.0090a>c |
C-peptide pt | 76.92 ± 7.44 | 85.77 ± 10.54 | 77.69 ± 10.49 | 0.51 |
C-peptide pv | 1,918 ± 134.1 | 1,867 ± 154.0 | 1,883 ± 152.6 | 0.86 |
Insulin pt | 60.77 ± 6.09 | 55.38 ± 5.90 | 42.31 ± 9.75 | 0.16 |
Insulin pv | 246.6 ± 20.17 | 234.2 ± 24.68 | 232.7 ± 24.14 | 0.76 |
Glucagon pt | 25.38 ± 4.62 | 36.92 ± 5.68 | 22.31 ± 3.03 | 0.12 |
Glucagon pv | 17.08 ± 2.01 | 18.31 ± 2.60 | 16.62 ± 2.07 | 0.19 |
CCK pt | 55.77 ± 14.38 | 36.15 ± 6.15 | 25.77 ± 5.48 | 0.096 |
CCK pv | 2.71 ± 0.36 | 2.73 ± 0.40 | 1.37 ± 0.16 | 0.0040a+b>c |
Triglycerides pt | 154.6 ± 9.52 | 110.8 ± 21.32 | 71.54 ± 17.50 | 0.0093a>c |
Triglycerides pv | 1.54 ± 0.23 | 1.37 ± 0.16 | 1.27 ± 0.18 | 0.19 |
Acetaminophen pt | 44.23 ± 12.30 | 43.85 ± 10.27 | 38.08 ± 5.98 | 0.69 |
Acetaminophen pv | 0.11 ± 0.01 | 0.12 ± 0.01 | 0.13 ± 0.01 | 0.681 |
Data are mean values ± SEM. All peak times in minutes, all peak values in pM except triglycerides and glucose in mM and acetaminophen in µM. P values are calculated using repeated measurement ANOVA. P-values ≤0.05 are considered statistically significant. Statistical significant difference between the three treatments is shown using the letters a, b and c, referring to the treatments
CCK cholecystokinin, GIP glucose-dependent insulinotropic polypeptide (intact), GLP-1 glucagon-like peptide-1 (total), iAUC incremental area under curve, PYY peptide YY, tAUC total area under curve